Pulmonary Mucormycosis Presenting as Nonresolving Pneumonia in a Patient With Diabetes Mellitus

References

1. 1.↵
   1. Petrikkos G,
   2. Skiada A,
   3. Lortholary O,
   4. Roilides E,
   5. Walsh TJ,
   6. Kontoyiannis DP

   . Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S23–S34.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Fishman AP,
   2. Elias JA,
   3. Fishman JA,
   4. Grippi MA,
   5. Senior RM,
   6. Pack AI

   1. Chamilos G,
   2. Kontoyiannis DP

   . Aspergillus, Candida, and other opportunistic mold infections of the lung. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI , editors. Fishman's pulmonary diseases and disorders, 4th edition, volume 2. New York: McGraw-Hill; 2008;2291–2326.

   OpenUrl
3. 3.↵
   1. Karnak D,
   2. Avery RK,
   3. Gildea TR,
   4. Sahoo D,
   5. Mehta AC

   . Endobronchial fungal disease: an under-recognized entity. Respiration 2007;74(1):88–104.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Di Carlo P,
   2. Cabibi D,
   3. La Rocca AM,
   4. De Luca D,
   5. La Licata F,
   6. Sacco E

   . Post-bronchoscopy fatal endobronchial hemorrhage in a woman with bronchopulmonary mucormycosis: a case report. J Med Case Rep 2010;4:398.

   OpenUrlPubMed
5. 5.↵
   1. Chamilos G,
   2. Marom EM,
   3. Lewis RE,
   4. Lionakis MS,
   5. Kontoyiannis DP

   . Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005;41(1):60–66.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Weyers CM,
   2. Leeper KV

   . Nonresolving pneumonia. Clin Chest Med 2005;26(1):143–158.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Ljubic S,
   2. Balachandran A,
   3. Pavlic-Renar I,
   4. Barada A,
   5. Metelko Z

   . Pulmonary infections in diabetes mellitus. Diabetol Croat 2004;33(4):115–124.

   OpenUrl
8. 8.↵
   1. Greenberg RN,
   2. Mullane K,
   3. van Burik JA,
   4. Raad I,
   5. Abzug MJ,
   6. Anstead G,
   7. et al

   . Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50(1):126–133.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. van Burik JA,
   2. Hare RS,
   3. Solomon HF,
   4. Corrado ML,
   5. Kontoyiannis DP

   . Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006;42(7):e61–e65.

   OpenUrlAbstract/FREE Full Text